【10月27日IPO雷达】丰倍生物申购

Core Viewpoint - The company Fengbei Biotechnology is set to launch an IPO with a total market value of 2.635 billion yuan and an issuance price of 24.49 yuan per share, indicating a competitive entry into the market with a focus on waste oil resource utilization and biofuel production [2][3]. Group 1: Company Overview - Fengbei Biotechnology has over 10 years of experience in the waste oil resource utilization sector, establishing a comprehensive industrial chain from waste oil to resource regeneration [2]. - The company has developed bio-based materials for agricultural applications and has a significant presence in the biofuel market, with a market share of approximately 4.68% in China's biodiesel sector by the end of 2024 [3]. Group 2: Financial Performance - The company reported a net profit of 1.948 billion yuan in the last three years, with a projected increase of 12.75% in 2024 [3]. - Revenue figures for the past three years are as follows: 1.728 billion yuan in 2023 (up 1.12%), and 1.709 billion yuan in 2022 (up 31.89%) [3]. Group 3: Business Highlights - The company’s main business segments include waste resource utilization (81.57%) and oil chemical products (18.29%), with minimal contributions from other areas (0.14%) [2]. - The company has established relationships with major clients in the biofuel sector, including TRAFIGURA and CARGILL, enhancing its market position [3]. Group 4: Fundraising Purpose - The funds raised from the IPO will be allocated to the construction of new production facilities, including 300,000 tons of oleic acid methyl ester, 10,000 tons of industrial-grade mixed oil, and 50,000 tons of biodiesel [3].